William Blair Investment Management, LLC Viatris Inc Transaction History

William Blair Investment Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$11.27 - $13.53 $123,834 - $148,667	-10,988 Reduced 35.55%	19,922 $237,000
Q4 2023 Feb 09, 2024	SELL	$8.77 - $10.85 $4,858 - $6,010	-554 Reduced 1.76%	30,910 $334,000
Q3 2023 Nov 09, 2023	BUY	$9.59 - $11.35 $113,123 - $133,884	11,796 Added 59.98%	31,464 $310,000
Q2 2023 Aug 10, 2023	SELL	$9.02 - $10.29 $441 - $504	-49 Reduced 0.25%	19,668 $196,000
Q1 2023 May 12, 2023	BUY	$9.2 - $12.26 $377 - $502	41 Added 0.21%	19,717 $189,000
Q4 2022 Feb 09, 2023	BUY	$8.72 - $11.56 $645 - $855	74 Added 0.38%	19,676 $218,000
Q3 2022 Nov 09, 2022	SELL	$8.48 - $11.13 $2,442 - $3,205	-288 Reduced 1.45%	19,602 $167,000
Q2 2022 Aug 10, 2022	SELL	$9.95 - $12.27 $165,776 - $204,430	-16,661 Reduced 45.58%	19,890 $208,000
Q1 2022 May 11, 2022	BUY	$9.81 - $15.4 $18,374 - $28,844	1,873 Added 5.4%	36,551 $398,000
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $105,545 - $128,156	8,730 Added 33.64%	34,678 $469,000
Q3 2021 Nov 10, 2021	BUY	$13.25 - $15.13 $343,811 - $392,593	25,948 New	25,948 $352,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of William Blair Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on William Blair Investment Management, LLC with notifications on news.